Communicable disease threats report, 18-24 July 2021, week 29
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 July 2021 and includes updates on Escherichia coli ST38, COVID-19, Vibrio growth in the Baltic Sea the Olympic Games in Tokyo 2020 (2021), West Nile virus, avian influenza and cholera.
Rapid risk assessment: Increase in OXA-244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013, first update
Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.
Shiga toxin-producing Escherichia coli (STEC) infection - Annual Epidemiological Report for 2019
For 2019, 29 EU/EEA countries reported 8 313 confirmed cases of Shiga toxin-producing Escherichia coli (STEC) infection.
The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2018/2019
In 2018–2019, data on antimicrobial resistance in zoonotic and indicator bacteria, submitted by 28 EU Member States (MSs), were jointly analysed by the EFSA and the ECDC.
The European Union One Health 2019 Zoonoses Report
This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2019 in 36 European countries (28 Member States (MS) and eight non-MS).
Campylobacter and Salmonella cases stable in the EU
The number of reported human cases of illness caused by Campylobacter and Salmonella bacteria across Europe appears to have stabilised over the past five years, according to the latest report on zoonotic diseases by EFSA and ECDC.
Surveillance systems overview for 2019
This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2019.
- Chikungunya virus disease
- Chlamydia infection
- Crimean-Congo haemorrhagic fever
- Ebola haemorrhagic fever
- Hantavirus infection
- Healthcare-associated infections
- Hepatitis A
- Hepatitis B
- Hepatitis C
- HIV infection
- Invasive Haemophilus influenzae disease
- Lassa fever
- Marburg haemorrhagic fever
- Meningococcal disease
- Pneumococcal disease
- Q fever
- Rift Valley fever
- Severe acute respiratory syndrome (SARS)
- Verotoxigenic Escherichia coli infection
- West Nile virus infection
Ninth external quality assessment scheme for typing of Shiga toxin-producing Escherichia coli
This report presents the results of the ninth round of the external quality assessment (EQA-9) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019
This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.
Shiga toxin/verocytotoxin-producing Escherichia coli (STEC/VTEC) infection - Annual Epidemiological Report for 2018
For 2018, 30 EU/EEA countries reported 8 658 confirmed cases of infection with Shigatoxin/verocytotoxin-producing Escherichia coli (STEC/VTEC).